BARRANTES-VARGAS v. SECRETARY OF HEALTH AND HUMAN SERVICES

No. 16-1515V.

CARLOS BARRANTES-VARGAS, Petitioner, v. SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent.

United States Court of Federal Claims.

Editors Note
Applicable Law: 42 U.S.C. § 300
Cause: 42 U.S.C. § 300 Vaccine Injury Act
Nature of Suit: 453 Injury - Pneumococcal Conjugate
Source: PACER


Attorney(s) appearing for the Case

CARLOS BARRANTES-VARGAS, Petitioner, represented by Kenneth W. Thayer, III , Gaylord Popp, LLC.

SECRETARY OF HEALTH AND HUMAN SERVICES, Respondent, represented by Lisa Ann Watts , U. S. Department of Justice - Vaccine.


Not to be Published

ORDER CONCLUDING PROCEEDINGS1

LAURA D. MILLMAN, Special Master.

On November 15, 2016, petitioner filed a petition under the National Childhood Vaccine Injury Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that influenza ("flu") and Pneumovax (PPV/23) vaccines administered on November 17, 2013 caused him positive HLA-B27 marker spondyloarthropathy. See Pet. Preamble.

On February 16, 2017, petitioner orally made a Motion for Voluntary Dismissal under Vaccine Rule 21(a)(1)(A).

DISCUSSION

Under Vaccine Rule 21(a)(1)(A), petitioner may engage in a voluntary dismissal by making a motion for dismissal at any time before service of respondent's Rule 4(c) Report, which petitioner has done in the instant action.

Under Vaccine Rule 21(a)(3), the result of this voluntary dismissal is an Order Concluding Proceedings. No judgment will enter pursuant to Vaccine Rule 11 for purposes of 42 U.S.C. § 300aa-21(a).

CONCLUSION

This petition is DISMISSED. The clerk of the court is directed to remove this case from the docket of the undersigned.

IT IS SO ORDERED.

FootNotes


1. Because this Order Concluding Proceedings contains a reasoned explanation for the special master's action in this case, the special master intends to post this Order Concluding Proceedings on the United States Court of Federal Claims' website, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). Vaccine Rule 18(b) states that all decisions of the special masters will be made available to the public unless they contain trade secrets or commercial or financial information that is privileged and confidential, or medical or similar information whose disclosure would constitute a clearly unwarranted invasion of privacy. When such a decision is filed, petitioners have 14 days to identify and move to redact such information prior to the document's disclosure. If the special master, upon review, agrees that the identified material fits within the categories listed above, the special master shall redact such material from public access.

Comment

1000 Characters Remaining

Leagle.com reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

User Comments

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases